$TTOO It’s amazing that this company has had to fight tooth and nail to get into 200 hospitals when CMS is endorsing and literally paying hospitals to use it. What else are hospitals not doing? Do they actually care about battling disease or is it about doing the bare minimum?
  • 17
@Biotek_Nvest @ns584 Also what’s really clear and accepted is LOS/mortality is reduced with appropriate ABX...so you have all these cases where you have an official diagnosis of culture negative sepsis where T2 redirects therapy...the “intellectual jump” you have to take without a comprehensive, multi center, definitive study to realize that there is a mortality/survival benefit is so small. This is what they argued with CMS and what physcians who use it routinely are saying.